5 Jul 2019
AFT signs new deal but maintains profit guidance
Drug company AFT Pharmaceuticals has signed a licensing deal potentially worth more than 10 million US dollars although it's held back lifting its profit forecast.
Drug company AFT Pharmaceuticals has signed a licensing deal potentially worth more than 10 million US dollars although it's held back lifting its profit forecast.